Stifel Financial Corp Bicycle Therapeutics PLC Transaction History

Stifel Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $411,110 - $1.49 Million	-31,746 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$40.12 - $59.5 $128,905 - $191,173	-3,213 Reduced 9.19%	31,746 $1.39 Million
Q4 2021 Feb 14, 2022	SELL	$41.7 - $61.14 $122,097 - $179,017	-2,928 Reduced 7.73%	34,959 $2.13 Million
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $118,815 - $188,064	-4,251 Reduced 10.09%	37,887 $1.58 Million
Q2 2021 Aug 13, 2021	BUY	$27.0 - $32.28 $1.14 Million - $1.36 Million	42,138 New	42,138 $1.28 Million

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $433M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.